AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 24 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,825,000 | -10.5% | 7,200,000 | 0.0% | 0.15% | -39.5% |
Q4 2018 | $5,391,000 | -0.1% | 7,200,000 | 0.0% | 0.24% | +48.2% |
Q3 2018 | $5,395,000 | -12.5% | 7,200,000 | -24.2% | 0.16% | -17.6% |
Q2 2018 | $6,165,000 | +176.6% | 9,500,000 | +143.0% | 0.20% | +237.3% |
Q2 2016 | $2,229,000 | -25.8% | 3,910,000 | -33.8% | 0.06% | -33.0% |
Q1 2016 | $3,003,000 | +352.3% | 5,910,000 | +491.0% | 0.09% | +388.9% |
Q4 2015 | $664,000 | – | 1,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 1,760,000 | $898,000 | 1.12% |
Telemetry Investments, L.L.C. | 6,000,000 | $3,049,000 | 0.89% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 54,500,000 | $27,693,000 | 0.46% |
ZAZOVE ASSOCIATES LLC | 15,070,000 | $7,761,000 | 0.37% |
ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $508,000 | 0.28% |
Tekla Capital Management LLC | 13,000,000 | $6,606,000 | 0.28% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $13,910,000,000 | 0.26% |
Castle Creek Arbitrage, LLC | 4,000,000 | $2,081,000 | 0.17% |
WOLVERINE ASSET MANAGEMENT LLC | 10,934,000 | $5,558,000 | 0.16% |
Baker Brothers Advisors | 26,517,000 | $13,526,000 | 0.14% |